232 related articles for article (PubMed ID: 12606608)
1. Antipsychotic dosing in preclinical models is often unrepresentative of the clinical condition: a suggested solution based on in vivo occupancy.
Kapur S; VanderSpek SC; Brownlee BA; Nobrega JN
J Pharmacol Exp Ther; 2003 May; 305(2):625-31. PubMed ID: 12606608
[TBL] [Abstract][Full Text] [Related]
2. Less is more: antipsychotic drug effects are greater with transient rather than continuous delivery.
Samaha AN; Reckless GE; Seeman P; Diwan M; Nobrega JN; Kapur S
Biol Psychiatry; 2008 Jul; 64(2):145-52. PubMed ID: 18295747
[TBL] [Abstract][Full Text] [Related]
3. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
4. The relationship between dopamine D2 receptor occupancy and the vacuous chewing movement syndrome in rats.
Turrone P; Remington G; Kapur S; Nobrega JN
Psychopharmacology (Berl); 2003 Jan; 165(2):166-71. PubMed ID: 12417967
[TBL] [Abstract][Full Text] [Related]
5. Modeling of brain D2 receptor occupancy-plasma concentration relationships with a novel antipsychotic, YKP1358, using serial PET scans in healthy volunteers.
Lim KS; Kwon JS; Jang IJ; Jeong JM; Lee JS; Kim HW; Kang WJ; Kim JR; Cho JY; Kim E; Yoo SY; Shin SG; Yu KS
Clin Pharmacol Ther; 2007 Feb; 81(2):252-8. PubMed ID: 17259948
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and time-course of D(2) receptor occupancy induced by atypical antipsychotics in stabilized schizophrenic patients.
Catafau AM; Penengo MM; Nucci G; Bullich S; Corripio I; Parellada E; García-Ribera C; Gomeni R; Merlo-Pich E;
J Psychopharmacol; 2008 Nov; 22(8):882-94. PubMed ID: 18308793
[TBL] [Abstract][Full Text] [Related]
7. Comparison of rat dopamine D2 receptor occupancy for a series of antipsychotic drugs measured using radiolabeled or nonlabeled raclopride tracer.
Barth VN; Chernet E; Martin LJ; Need AB; Rash KS; Morin M; Phebus LA
Life Sci; 2006 May; 78(26):3007-12. PubMed ID: 16434058
[TBL] [Abstract][Full Text] [Related]
8. Dopamine D(2) receptor occupancy is a common mechanism underlying animal models of antipsychotics and their clinical effects.
Wadenberg ML; Soliman A; VanderSpek SC; Kapur S
Neuropsychopharmacology; 2001 Nov; 25(5):633-41. PubMed ID: 11682246
[TBL] [Abstract][Full Text] [Related]
9. S33138 (N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1] benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenyl-acetamide), a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent: III. Actions in models of therapeutic activity and induction of side effects.
Millan MJ; Loiseau F; Dekeyne A; Gobert A; Flik G; Cremers TI; Rivet JM; Sicard D; Billiras R; Brocco M
J Pharmacol Exp Ther; 2008 Mar; 324(3):1212-26. PubMed ID: 18096759
[TBL] [Abstract][Full Text] [Related]
10. Nicotine-antipsychotic drug interactions and attentional performance in female rats.
Rezvani AH; Levin ED
Eur J Pharmacol; 2004 Feb; 486(2):175-82. PubMed ID: 14975706
[TBL] [Abstract][Full Text] [Related]
11. Neuroleptics and animal models: feasibility of oral treatment monitored by plasma levels and receptor occupancy assays.
Perez-Costas E; Guidetti P; Melendez-Ferro M; Kelley JJ; Roberts RC
J Neural Transm (Vienna); 2008 May; 115(5):745-53. PubMed ID: 18193153
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of within-day continuous vs. transient dopamine D2 receptor occupancy in the development of vacuous chewing movements (VCMs) in rats.
Turrone P; Remington G; Kapur S; Nobrega JN
Neuropsychopharmacology; 2003 Aug; 28(8):1433-9. PubMed ID: 12838271
[TBL] [Abstract][Full Text] [Related]
13. Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice.
Goodwin G; Fleischhacker W; Arango C; Baumann P; Davidson M; de Hert M; Falkai P; Kapur S; Leucht S; Licht R; Naber D; O'Keane V; Papakostas G; Vieta E; Zohar J
Eur Neuropsychopharmacol; 2009 Jul; 19(7):520-32. PubMed ID: 19411165
[TBL] [Abstract][Full Text] [Related]
14. Striatal dopaminergic D2 receptor occupancy and clinical efficacy in psychosis exacerbation: a 123I-IBZM study with ziprasidone and haloperidol.
Corripio I; Catafau AM; Perez V; Puigdemont D; Mena E; Aguilar Y; Carrió I; Alvarez E
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):91-6. PubMed ID: 15610950
[TBL] [Abstract][Full Text] [Related]
15. Prediction and assessment of extrapyramidal side effects induced by risperidone based on dopamine D(2) receptor occupancy.
Yamada Y; Ohno Y; Nakashima Y; Fukuda M; Takayanagi R; Sato H; Tsuchiya F; Sawada Y; Iga T
Synapse; 2002 Oct; 46(1):32-7. PubMed ID: 12211096
[TBL] [Abstract][Full Text] [Related]
16. Pyrrolo[1,3]benzothiazepine-based serotonin and dopamine receptor antagonists. Molecular modeling, further structure-activity relationship studies, and identification of novel atypical antipsychotic agents.
Campiani G; Butini S; Fattorusso C; Catalanotti B; Gemma S; Nacci V; Morelli E; Cagnotto A; Mereghetti I; Mennini T; Carli M; Minetti P; Di Cesare MA; Mastroianni D; Scafetta N; Galletti B; Stasi MA; Castorina M; Pacifici L; Vertechy M; Di Serio S; Ghirardi O; Tinti O; Carminati P
J Med Chem; 2004 Jan; 47(1):143-57. PubMed ID: 14695828
[TBL] [Abstract][Full Text] [Related]
17. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.
Kane JM; Leucht S; Carpenter D; Docherty JP;
J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142
[TBL] [Abstract][Full Text] [Related]
18. Quetiapine: preclinical studies, pharmacokinetics, drug interactions, and dosing.
Nemeroff CB; Kinkead B; Goldstein J
J Clin Psychiatry; 2002; 63 Suppl 13():5-11. PubMed ID: 12562141
[TBL] [Abstract][Full Text] [Related]
19. Are animal studies of antipsychotics appropriately dosed? Lessons from the bedside to the bench.
Kapur S; Wadenberg ML; Remington G
Can J Psychiatry; 2000 Apr; 45(3):241-6. PubMed ID: 10779880
[TBL] [Abstract][Full Text] [Related]
20. Long-term effects of JL 13, a potential atypical antipsychotic, on rat dopamine and serotonin receptor subtypes.
Moran-Gates T; Massari C; Graulich A; Liégeois JF; Tarazi FI
J Neurosci Res; 2006 Aug; 84(3):675-82. PubMed ID: 16810690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
